AI assistant
Sending…
Relay Therapeutics, Inc. — Director's Dealing 2021
Feb 20, 2021
32320_dirs_2021-02-19_1da930e8-6cec-4066-a826-f6da447961b1.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: Relay Therapeutics, Inc. (RLAY)
CIK: 0001812364
Period of Report: 2021-02-19
Reporting Person: Borisy Alexis (Director)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2021-02-19 | Common Stock | J | 30194 | $0.00 | Acquired | 205637 | Direct |
Footnotes
F1: Pro rata distribution from Third Rock Ventures GP III, L.P., of which the reporting person is a limited partner.
More from Relay Therapeutics, Inc.
Share Issue/Capital Change
2026
May 21
Capital/Financing Update
2026
May 21
Capital/Financing Update
2026
May 19
Regulatory Filings
2026
May 19
Regulatory Filings
2026
Apr 27
Annual Report
2026
Feb 26
Earnings Release
2026
Feb 26
Major Shareholding Notification
2026
Feb 17
Regulatory Filings
2026
Feb 3
Director's Dealing
2026
Jan 29